rehabilitation methods and the use of serotonin norepinephrine reuptake inhibitors (venlafaxine) in the treatment of patients with persistent postural perceptual dizziness
Phase 2
- Conditions
- Persistent postural perceptual dizziness.Dizziness and giddiness
- Registration Number
- IRCT20230803059017N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Comparison of two vestibular rehabilitation methods and the use of serotonin norepinephrine reuptake inhibitors (venlafaxine) in the treatment of patients with persistent postural perceptual dizziness.
Age over 18 years and under 65 years
Informed consent to participate in the study
Dizziness Handicap Inventory (DHI) >16
Exclusion Criteria
Having psychiatric and/or cognitive disorders that prevent understanding tests and questionnaires.
Using drugs that cause dizziness
Having brain structural disorders
Having high blood pressure
Having a history of heart disease such as heart failure and heart attack
hyperthyroidism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dizziness. Timepoint: before and after treatment (6 weeks later). Method of measurement: dizziness handicap inventory.
- Secondary Outcome Measures
Name Time Method